NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE80435 Query DataSets for GSE80435
Status Public on Dec 01, 2017
Title Whole genome landscapes of major melanoma subtypes
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Cutaneous, acral and mucosal subtypes of melanoma were evaluated by whole-genome sequencing, revealing genes affected by novel recurrent mutations to the promoter (TERT, DPH3, OXNAD1, RPL13A, RALY, RPL18A, AP2A1), 5’-UTR (HNRNPUL1, CCDC77, PES1), and 3’-UTR (DYNAP, CHIT1, FUT9, CCDC141, CDH9, PTPRT) regions. TERT promoter mutations had the highest frequency of any mutation, but neither they nor ATRX mutations, associated with the alternative telomere lengthening mechanism, were correlated with greater telomere length. Genomic landscapes largely reflected ultraviolet radiation mutagenesis in cutaneous melanoma and provided novel insights into melanoma pathogenesis. In contrast, acral and mucosal melanomas exhibited predominantly structural changes, and mutation signatures of unknown aetiology not previously identified in melanoma. The majority of melanomas had potentially actionable mutations, most of which were in components of the mitogen-activated protein kinase and phosphoinositol kinase pathways.
 
Overall design Expression arrays from 65 of the 183 tumours analysed were used to determine gene expression levels of genes with recurrent promoter and 3' and 5' UTR mutations. A total of 32 samples is available at GSE54467; the remaining 33 samples are submitted here. The 27 primary melanoma samples (AJCC stage II) were assayed using the HumanHT-12 v4 Expression BeadChip (Illumina® Inc., San Diego, CA, USA; Catalog IDs: BD-103-0204, BD-103-0604). The remaining 6 metastatic (AJCC stage IV) samples were assayed using the HumanWG-6 v3 Expression BeadChip ((Illumina® Inc., San Diego, CA, USA; Catalog IDs: BD-101-0203, BD-101-0603). NEQC normalisation (default parameters) was separately applied to each of the AJCC stage II and IV datasets (http://0-nar-oxfordjournals-org.brum.beds.ac.uk/content/38/22/e204). Probes for which there were no samples with a detection p-value of less than 0.01 were removed.
 
Contributor(s) Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, Patch A, Kakavand H, Alexandrov LB, Burke H, Jakrot V, Kazakoff S, Holmes O, Leonard C, Wood S, Xu Q, Waddell N, Tembe V, Pupo GM, De Paoli-Iseppi R, Vilain RE, Shang P, Schramm S, Pritchard A, Dutton-Regester K, Fitzgerald A, Shang CA, Grimmond SM, Yang JY, Stretch JR, Kefford RF, Hersey P, Long GV, Cebon J, Shackleton M, Spillane AJ, Saw RP, Pearson JV, Thompson JF, Scolyer RA, Mann GJ
Citation(s) 28467829
Submission date Apr 19, 2016
Last update date Feb 18, 2019
Contact name Graham J. Mann
E-mail(s) graham.mann@sydney.edu.au
Organization name Melanoma Institute Australia
Street address Poche Centre, 40 Rocklands Road
City North Sydney
State/province NSW
ZIP/Postal code 2060
Country Australia
 
Platforms (2)
GPL6884 Illumina HumanWG-6 v3.0 expression beadchip
GPL10558 Illumina HumanHT-12 V4.0 expression beadchip
Samples (33)
GSM2127253 MELA_0018
GSM2127254 MELA_0225
GSM2127255 MELA_0216
Relations
BioProject PRJNA318904

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE80435_RAW.tar 32.4 Mb (http)(custom) TAR
GSE80435_non_normalized_stage_2.txt.gz 7.9 Mb (ftp)(http) TXT
GSE80435_non_normalized_stage_4.txt.gz 2.0 Mb (ftp)(http) TXT
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap